Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-11

FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' generic pregabalin product through an abbreviated new drug application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)